SCHEMBL18565324

SCHEMBL18565324

c1ccc(-c2cc(-c3ccccc3)cc(N(c3cc(-c4ccccc4)cc(-c4ccccc4)c3)c3ccc4c(c3)c3ccccc3n4-c3cccc(-c4nc(-c5cccc(-n6c7ccccc7c7cc(N(c8cc(-c9ccccc9)cc(-c9ccccc9)c8)c8cc(-c9ccccc9)cc(-c9ccccc9)c8)ccc76)c5)nc(-c5cccc(-n6c7ccccc7c7cc(N(c8cc(-c9ccccc9)cc(-c9ccccc9)c8)c8cc(-c9ccccc9)cc(-c9ccccc9)c8)ccc76)c5)n4)c3)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32
PTGER4 P35408 1/20 0.31
PDE10A Q9Y233 1/20 0.31
RAC2 P15153 1/20 0.31
RAC3 P60763 1/20 0.31
CDC42 P60953 1/20 0.31
RAC1 P63000 1/20 0.31
TSPO P30536 1/20 0.30
OPRD1 P41143 1/20 0.30
PLA2G10 O15496 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18565327 0.95 KDM4E (0.39) KDM4EATML3MBTL1MEN1GAA
SCHEMBL18565322 0.94 KDM4E (0.36) KDM4EATML3MBTL1MEN1GAA
SCHEMBL19845455 0.94 ATM (0.38) KDM4EATML3MBTL1MEN1GAA
SCHEMBL19845458 0.93 ATM (0.39) KDM4EATML3MBTL1MEN1GAA
SCHEMBL18511455 0.93 KDM4E (0.42) KDM4EATML3MBTL1MEN1GAA
SCHEMBL18565216 0.92 KDM4E (0.41) KDM4EATML3MBTL1MEN1GAA
SCHEMBL19845497 0.91 KDM4E (0.35) KDM4EATML3MBTL1PTGER4PDE10A
SCHEMBL15785781 0.91 KDM4E (0.39) KDM4EATML3MBTL1MEN1GAA
SCHEMBL16383406 0.91 L3MBTL1 (0.42) KDM4EATML3MBTL1MEN1KMT2A
SCHEMBL18565308 0.91 TSPO (0.39) KDM4EATML3MBTL1MEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-05-14 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-03-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10290815-B2 Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device EED, BMI1, CD99 KDM4E 225/4885ATM 3092/4885L3MBTL1 1263/4885
US-20170062733-A1 COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE EED, BMI1, CD99 KDM4E 225/4885ATM 3092/4885L3MBTL1 1263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.